Implant Sciences/CardioTech
This article was originally published in The Gray Sheet
Executive Summary
Phase I Small Business Innovation Research Grant of $100,000 from NIH awarded to conduct research targeting improvements in drug delivery to abdominal aortic aneurysm (AAA) sites by incorporating heparin and rapamycin drugs into non-erodable, biodurable polyurethane graft coatings. Implant Sciences will provide a self-expanding, gold-coated Nitinol stent for improved radiopaque visualization, while CardioTech will contribute its ChronoFlex biodurable polyurethane loaded with rapamycin and coated with heparin. After a six-month trial is complete, an additional $750,000 Phase II grant may be available to develop the device into a commercial product...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.